In this issue:
Guselkumab in Japanese patients with palmoplantar pustulosis
Cost of first-line rituximab vs corticosteroids for pemphigus
Ixekizumab: long-term efficacy of Q2W vs Q4W dosing
Ixekizumab or secukinumab for psoriasis: real-world data
Brodalumab for moderate-tosevere plaque psoriasis
Effect of biological treatment on fatigue in psoriasis
Adalimumab for nail psoriasis
Ustekinumab treatment for hidradenitis suppurativa
Nivolumab vs ipilimumab as adjuvant therapy in stage III/IV melanoma
Please login below to download this issue (PDF)